Skip to the page

Data / Form D filings / FYR Diagnostics, Inc.

FYR Diagnostics, Inc.: Form D filing

FYR Diagnostics, Inc., a biotechnology company in Missoula, MT, filed a Form D with the SEC in 2024. The latest, on August 16, 2024, reports $8 million sold of a $12 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1121 E BROADWAY STREET, Missoula, MT, 59802
Phone
(406) 303-3560
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2033993

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 16, 2024New notice$12,002,173$8,002,176$3,999,9972Aug 2, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brian ConwayExecutive Officer
Michael GoguenDirector
Avery SonnenbergDirector
Sarjubhai PatelExecutive Officer, Director
Christopher BoothExecutive Officer, Director

Other biotechnology companies in Montana that filed recently

Every Form D from the week of Aug 12, 2024 · All recent filings in Montana · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what FYR Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.